Related Experiment Videos
Hypertensive heart disease--significance of left ventricular hypertrophy
1Medical Clinic/Nephrology, University of Erlangen-Nürnberg, Germany.
Insights
Left ventricular hypertrophy, an early sign of hypertension, increases cardiovascular risks. Specific antihypertensive therapies can reduce this cardiac change and improve patient outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Echocardiography
Background:
- Left ventricular hypertrophy is an early cardiac adaptation to hypertension.
- Left ventricular hypertrophy significantly elevates risks for coronary artery disease, heart failure, and sudden death.
- These risks are elevated independently of blood pressure levels.
Purpose of the Study:
- To highlight the significance of left ventricular hypertrophy in hypertension.
- To emphasize the need for antihypertensive therapies targeting both blood pressure and left ventricular mass.
- To present evidence for improved cardiovascular prognosis with left ventricular hypertrophy regression.
Main Methods:
- Echocardiography for precise measurement of left ventricular hypertrophy.
- Analysis of clinical studies on antihypertensive agents.
- Evaluation of cardiovascular outcomes following regression of left ventricular hypertrophy.
Main Results:
- Left ventricular hypertrophy can be accurately measured using echocardiography.
- Regression of left ventricular hypertrophy is associated with improved cardiovascular prognosis.
- Certain antihypertensive agents effectively reduce both blood pressure and left ventricular mass.
Conclusions:
- Left ventricular hypertrophy is a critical cardiovascular risk factor in hypertension.
- Targeted antihypertensive therapy is essential for managing left ventricular hypertrophy.
- Regression of left ventricular hypertrophy improves cardiovascular outcomes.
Abstract:
One of the earliest structural changes in the heart adapting to hypertension is left ventricular hypertrophy, which can now be exactly measured by echocardiography. Left ventricular hypertrophy increases the incidence of coronary artery disease, heart failure, and sudden death severalfold, independent of the blood pressure levels. Left ventricular hypertrophy requires specific antihypertensive therapy that controls both high blood pressure and increased left ventricular mass. Preliminary data from clinical studies indicate that regression of left ventricular hypertrophy leads to a better cardiovascular prognosis. Sympatholytic substances, angiotensin-converting enzyme (ACE) inhibitors, and calcium antagonists are antihypertensive agents that effected adequate reductions in blood pressure as well as regression of left ventricular hypertrophy.